Congratulations to the team at Genesis Care Sydney. The team have set a new treatment record on an MRLinac with 20 patients treated in one day with a fully adaptive treatment including 11 stereotactic cases. ‘Putting our patients first and ensuring everyone receives rapid access to treatment makes the long days worth it.’ – Genesis …
The MR-Linac team at the Christie shares an update on their activities. A few things to highlight: They rolled out the ATS-lite workflow for prostate patients to increase efficiency, they are planning for their first liver treatment and 6 radiographers have had abstracts accepted for presentation at ESTRO24 meeting in Glasgow. Click here to read …
In the MOMENTUM study, including 1772 patients treated on a 1.5-T MR-Linac, radiotherapy was safe and well tolerated. Online adaptation of the radiation plan at each treatment session to account for anatomic variations was associated with a low risk of acute grade 3 toxic effects. …
This year at ESTRO, for the first time, we had a Consortium event during which we invited non-consortium members and MRIdian users to learn more about the Consortium’s activities and MRgRT in general. We had 150 members attend, and in total 250 people came to learn more about the MR-Linac Consortium and our global …
Congratulations to researcher, Dr. Lois Daamen from our member site UMC Utrecht in the Netherlands. She was recognized for her oral presentation during recent MRinRT symposium in Rome. Using MOMENTUM data, she presented Quality of life and toxicity in patients with pancreatic adenocarcinoma treated with a 1.5 Tesla MR-Linac. Congratulations Lois on your excellent work. …
Read More… from Congratulations to researcher, Dr. Lois Daamen – UMCU
RIF Radiotherapeutisch Instituut Friesland in Leeuwarden NL have treated their first patient with renal cell carcinoma on the Elekta MR-Linac was irradiated at the RIF. There are only a few centers in the Netherlands that can do this MRI-driven. This is a great step forward for both the RIF and their patients. The photo shows …
